Tri Femynor
These highlights do not include all the information needed to use TRI FEMYNOR safely and effectively. See full prescribing information for TRI FEMYNOR. TRI FEMYNOR™ (norgestimate and ethinyl estradiol) tablets, for oral use Initial U.S. Approval: 1989
Approved
Approval ID
46bbdf70-2b80-4359-a19b-d94ff99eac98
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Aug 30, 2016
Manufacturers
FDA
Amneal Pharmaceuticals NY LLC
DUNS: 123797875
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
norgestimate and ethinyl estradiol
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code69238-1607
Application NumberANDA203870
Product Classification
M
Marketing Category
C73584
G
Generic Name
norgestimate and ethinyl estradiol
Product Specifications
Effective DateAugust 30, 2016
FDA Product Classification